Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient care

Patricia Lindberg-Scharf, Brunhilde Steinger, Michael Koller, Andrea Hofstädter, Olaf Ortmann, Jan Kurz, Jonathan Sasse, Monika Klinkhammer-Schalke, Patricia Lindberg-Scharf, Brunhilde Steinger, Michael Koller, Andrea Hofstädter, Olaf Ortmann, Jan Kurz, Jonathan Sasse, Monika Klinkhammer-Schalke

Abstract

Purpose: The effectiveness of a pathway with quality of life (QoL) diagnosis and therapy has been already demonstrated in an earlier randomized trial (RCT) in patients with breast cancer. We refined the pathway by developing and evaluating an electronic tool for QoL assessment in routine inpatient and outpatient care.

Methods: In a single-arm study, patients with breast cancer with surgical treatment in two German hospitals were enrolled. QoL (EORTC QLQ-C30, QLQ-BR23) was measured with an electronic tool after surgery and during aftercare in outpatient medical practices (3, 6, 9, 12, 18, and 24 months) so that results (QoL-profile) were available immediately. Feedback by patients and physicians was analyzed to evaluate feasibility and impact on patient-physician communication.

Results: Between May 2016 and July 2018, 56 patients were enrolled. Physicians evaluated the QoL pathway as feasible. Patients whose physician regularly discussed QoL-profiles with them reported significantly more often that their specific needs were cared for (p < .001) and that their physician had found the right treatment strategy for these needs (p < .001) compared with patients whose doctor never/rarely discussed QoL-profiles. The latter significantly more often had no benefit from QoL assessments (p < .001).

Conclusion: The QoL pathway with electronic QoL assessments is feasible for inpatient and outpatient care. QoL results should be discussed directly with the patient.

Clinical trial information: NCT04334096, date of registration 06.04.2020.

Keywords: Breast cancer; Complex intervention; Electronic assessment; Patient-physician communication; Patient-reported outcomes; Quality of life.

Conflict of interest statement

The authors declare that they have no conflict of interest.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Quality of life (QoL-) profile: woman with primary breast cancer, 49 years, married, one child, working. Prognostic classification pT1b(m), SN0, M0, G1, ER pos, PR pos, HER2 neg; breast-conserving surgical therapy with revision surgery after 1 month followed by radiation and anti-estrogen treatment. Red bar = cutoff for a need for QoL therapy (

Fig. 2

Flow chart

Fig. 2

Flow chart

Fig. 2
Flow chart

Fig. 3

Rates of patients with a…

Fig. 3

Rates of patients with a need for quality of life (QoL) therapy (QoL…

Fig. 3
Rates of patients with a need for quality of life (QoL) therapy (QoL χ2 tests: 0 months p = .54, 3 months p = .32, 6 months p = .14, 9 months p = .66, 12 months p = .77
Fig. 2
Fig. 2
Flow chart
Fig. 3
Fig. 3
Rates of patients with a need for quality of life (QoL) therapy (QoL χ2 tests: 0 months p = .54, 3 months p = .32, 6 months p = .14, 9 months p = .66, 12 months p = .77

References

    1. Wöckel A, Schwentner L, Krockenberger M, Kreienberg R, Janni W, Wischnewsky M, Thorsten K, Felix F, Riccardo F, Blettner M, Singer S. Predictors of the course of quality of life during therapy in women with primary breast cancer. Qual Life Res. 2017;26(8):2201–2208. doi: 10.1007/s11136-017-1570-0.
    1. Couwenberg AM, Burbach JPM, van Grevenstein WMU, Smits AB, Consten ECJ, Schiphorst AHW, Wijffels NAT, Heikens JT, Intven MPW, Verkooijen HM. Effect of neoadjuvant therapy and rectal surgery on health-related quality of life in patients with rectal cancer during the first 2 years after diagnosis. Clin Colorectal Cancer. 2018;17(3):e499–e512. doi: 10.1016/j.clcc.2018.03.009.
    1. Detmar SB, Aaronson NK, Wever LDV, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality-of-life issues. J Clin Oncol. 2000;18:3295–3301. doi: 10.1200/JCO.2000.18.18.3295.
    1. Braeken APBM, Kempen GIJM, Eekers D, van Gils FCJM, Houben RMA, Lechner L. The usefulness and feasibility of a screening instrument to identify psychosocial problems in patients receiving curative radiotherapy: a process evaluation. BMC Cancer. 2011;11:479. doi: 10.1186/1471-2407-11-479.
    1. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Jr, Vaporciyan AA. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011;29:994–1000. doi: 10.1200/JCO.2010.29.8315.
    1. Detmar S, Muller M, Schornagel J, Wever LDV, Aaronson NK. Health-related quality-of-life assessments and patient-physician communication A randomized controlled trial. JAMA. 2002;288:3027–3034. doi: 10.1001/jama.288.23.3027.
    1. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, Selby PJ. Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol. 2004;22:714–724. doi: 10.1200/JCO.2004.06.078.
    1. Berry DL, Blumenstein BA, Halpenny B, Wolpin S, Fann JR, Austin-Seymour M, Bush N, Karras BT, Lober WB, McCorkle R. Enhancing patient-provider communication with the electronic self-report assessment for cancer: a randomized trial. J Clin Oncol. 2011;29:1029–1035. doi: 10.1200/JCO.2010.30.3909.
    1. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF, Dulko D, Sit L, Barz A, Novotny P, Fruscione M, Sloan JA, Schrag D. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557–5565. doi: 10.1200/JCO.2015.63.0830.
    1. Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, Bourgeois H, Senellart H, Trémolières P, Lizée T, Bennouna J, Urban T, El Khouri C, Charron A, Septans AL, Balavoine M, Landry S, Solal-Céligny P, Letellier C (2017) Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. JNCI J Natl Cancer Inst 109(9). 10.1093/jnci/djx029
    1. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter P, Tyrer P. Framework for design and evaluation of complex interventions to improve health. BMJ. 2000;321:694–696. doi: 10.1136/bmj.321.7262.694.
    1. Craig P, Dieppe P, Macintyre S, Mitchie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:979–983. doi: 10.1136/bmj.a1655.
    1. Klinkhammer-Schalke M, Koller M, Steinger B, Ehret C, Ernst B, Wyatt JC, Hofstädter F, Lorenz W. Direct improvement of quality of life using a tailored quality of life diagnosis and therapy approach: randomized trial in 200 women with breast cancer. Br J Cancer. 2012;106:826–838. doi: 10.1038/bjc.2012.4.
    1. Klinkhammer-Schalke M, Steinger B, Koller M, Zeman F, Fürst A, Gumpp J, Obermaier R, Piso P, Lindberg-Scharf P. Diagnosing deficits in quality of life and providing tailored therapeutic options: results of a randomised trial in 220 patients with colorectal cancer. Eur J Cancer. 2020;130:102–113. doi: 10.1016/j.ejca.2020.01.025.
    1. Gwaltney CJ, Shields AL, Shiffman S. Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review. Value Health. 2008;11:322–33. doi: 10.1111/j.1524-4733.2007.00231.x.
    1. Muehlhausen W, Doll H, Quadri N, Fordham B, O’Donohoe P, Dogar N, Wild DJ. Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual Life Outcomes. 2015;13:167. doi: 10.1186/s12955-015-0362-x.
    1. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2020) S3-Leitlinie Früherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.3. AWMF Registernummer: 032–045OL. . Accessed 27 April 2020
    1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376. doi: 10.1093/jnci/85.5.365.
    1. Sprangers MAG, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14:2756–2768. doi: 10.1200/JCO.1996.14.10.2756.
    1. Fayers P, Aaronson N, Bjordal K, Curran D, Groenvold M. EORTC QLQ-C30 scoring manual. 9. Brussels: EORTC Study Group on Quality of Life; 2001.
    1. Snyder CF, Smith K, Bantug E, Tolbert EE, Blackford AL, Brundage MD. What do these scores mean? Presenting patient-reported outcomes data to patients and clinicians to improve interpretability. Cancer. 2017;123:1848–1859. doi: 10.1002/cncr.30530.
    1. Koller M, Lorenz W. Quality of life: a deconstruction for clinicians. J R Soc Med. 2002;95:481–488. doi: 10.1258/jrsm.95.10.481.
    1. Klinkhammer-Schalke M, Koller M, Wyatt JC, Steinger B, Ehret C, Ernst B, Hofstädter F, Lorenz W. Quality of life diagnosis and therapy as complex intervention for improvement of health in breast cancer patients: delineating the conceptual, methodological, and logistic requirements (modeling) Langenbecks Arch Surg. 2008;393:1–12. doi: 10.1007/s00423-007-0210-5.
    1. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003;362:1225–1230. doi: 10.1016/S0140-6736(03)14546-1.
    1. Joseph-Williams N, Elwyn G, Edwards A. Knowledge is not power for patients: a systematic review and thematic synthesis of patient-reported barriers and facilitators to shared decision making. Patient Educ Couns. 2014;94:291–309. doi: 10.1016/j.pec.2013.10.031.
    1. Wysham NG, Wolf SP, Samsa G, Abernethy AP, LeBlanc TW. Integration of electronic patient-reported outcomes into routine cancer care: an analysis of factors affecting data completeness. JCO Clinical Cancer Informatics. 2017 doi: 10.1200/CCI.16.00043.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit